tldrdailynews.com logo

"Shah Capital's Push for Novavax Board Shake-Up Amid Vaccine Struggles"

1 min read
Source: Financial Times
TL;DR

A hedge fund is pushing for a board shake-up at Novavax due to the struggles of its Covid vaccine. The fund is urging the company to consider changes to its board composition in order to improve its performance in the development and distribution of the vaccine.

Topics:business#board-shake-up#business#covid-vaccine#financial-times#hedge-fund#novavax
Share this article
  1. Hedge fund urges board shake-up at Novavax over struggling Covid vaccine  Financial Times
  2. Novavax failed to capitalize on fears surrounding mRNA vaccines, activist investor says  MarketWatch
  3. Shah Capital nominates two highly qualified independent director candidates for Novavax  Yahoo Finance
  4. Novavax (NASDAQ:NVAX) Jumps Amid Activist Investor Push - TipRanks.com  TipRanks
  5. US-based Hedge fund Shah Capital urges Novavax board shake-up: Report  Business Standard

Want the full story? Read the original reporting

Read on Financial Times